Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

Yao-Jun Zhang1,2, MD, PhD; Christos V. Bourantas1, MD, PhD; Takashi Muramatsu1, MD, PhD; Javaid Iqbal1, MRCP, PhD; Vasim Farooq1, MBChB, MRCP; Roberto Diletti1, MD; Carlos A.M. Campos1,3, MD; Yoshinobu Onuma1, MD; Hector M. Garcia-Garcia1, MD, PhD; Patrick W. Serruys1*, MD, PhD

1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China; 3. Heart Institute (InCor), University of São Paulo Medical School, Sao Paulo, Brazil

Aims: The study sought to compare the acute gain and two-year follow-up late lumen loss (LLL) between the Absorb bioresorbable vascular scaffold (BVS) and the analogous everolimus-eluting

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

acute gainbioresorbable vascular scaffoldeverolimus-eluting stentlate lumen lossminimal lumen area

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Incidence and impact on midterm outcome of controlled subintimal tracking in patients with successful recanalisation of chronic total occlusions: J-PROCTOR registry